Sangamo Therapeutics (SGMO)

$0.11 -0.07 (-37.27%)
Market Cap 73.58M
Revenue (ttm) 39.55M
Net Income (ttm) -122.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -310.82%
Debt to Equity Ratio 0.00
Volume 44,541,699
Avg Vol 10,731,998
Day's Range N/A - N/A
Shares Out 414.28M
Stochastic %K 4%
Beta 1.04
Analysts Sell
Price Target $3.75

Company Profile

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fiber neuropathy for chronic neuropathic pain, and prion disease; Phase 1/2 clinical trial to evaluate the...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 970 6000
Address:
501 Canal Blvd, Richmond, United States
rjalagam9111
rjalagam9111 Jun. 9 at 3:22 AM
$SGMO do you think Nav 1.7 and Prion will be on hold or they will continue with trials as planned until sold ?
0 · Reply
Chipoo
Chipoo Jun. 9 at 12:22 AM
$SGMO Sell it for $1.00 and a CVR
1 · Reply
rjalagam9111
rjalagam9111 Jun. 9 at 12:21 AM
$SGMO They still want to advance pipeline ? What that means ? Sell only Hem A & Fabry ?
1 · Reply
gimoozaabi
gimoozaabi Jun. 9 at 12:11 AM
$SGMO “retained Raymond James as its financial advisor to assist in evaluating a full range of strategic alternatives to advance its promising pipeline and to maximize value for all stakeholders” In other words, they admit **that we don’t know shit what we were doing, so hopefully this guy we hired will make something out of our pipeline.** I don’t think there’s going to be any appeal for up listings, and the only hope is that they find a buyer before having to turn off the lights.
1 · Reply
lukeglue
lukeglue Jun. 9 at 12:00 AM
$SGMO “goin down down baby yo street in a Range Rover” - $$$ANDY
0 · Reply
soonwee640
soonwee640 Jun. 8 at 10:30 PM
$SGMO IMO, 2 possibility: 1)Those bids to buy entire company are just too low, RJ told them to issue PR opening the door to see if a competitor will outbid them. 2)The PR is a legally required formal routine before the signature. In fact, probably they already engaging with the buyer.
0 · Reply
Chipoo
Chipoo Jun. 8 at 10:13 PM
$SGMO Wondering if today's PR is to shield SGMO from any lawsuits from warrent holders...
1 · Reply
Patrick2343
Patrick2343 Jun. 8 at 10:06 PM
$SGMO Notice all the pumpers have gone MIA too. The guy who usally pumps this every am. Soren. Even biotech toned it down.
0 · Reply
Scooter0732
Scooter0732 Jun. 8 at 9:51 PM
$SGMO this is the correct interpretation.
0 · Reply
kiwiSurfer
kiwiSurfer Jun. 8 at 9:17 PM
$SGMO the specious reasoning that a BK filing would allow shareholders to get residual value of assets is not correct generally they do not. The shareholders can and do get the shaft.
0 · Reply
Latest News on SGMO
No data available.
rjalagam9111
rjalagam9111 Jun. 9 at 3:22 AM
$SGMO do you think Nav 1.7 and Prion will be on hold or they will continue with trials as planned until sold ?
0 · Reply
Chipoo
Chipoo Jun. 9 at 12:22 AM
$SGMO Sell it for $1.00 and a CVR
1 · Reply
rjalagam9111
rjalagam9111 Jun. 9 at 12:21 AM
$SGMO They still want to advance pipeline ? What that means ? Sell only Hem A & Fabry ?
1 · Reply
gimoozaabi
gimoozaabi Jun. 9 at 12:11 AM
$SGMO “retained Raymond James as its financial advisor to assist in evaluating a full range of strategic alternatives to advance its promising pipeline and to maximize value for all stakeholders” In other words, they admit **that we don’t know shit what we were doing, so hopefully this guy we hired will make something out of our pipeline.** I don’t think there’s going to be any appeal for up listings, and the only hope is that they find a buyer before having to turn off the lights.
1 · Reply
lukeglue
lukeglue Jun. 9 at 12:00 AM
$SGMO “goin down down baby yo street in a Range Rover” - $$$ANDY
0 · Reply
soonwee640
soonwee640 Jun. 8 at 10:30 PM
$SGMO IMO, 2 possibility: 1)Those bids to buy entire company are just too low, RJ told them to issue PR opening the door to see if a competitor will outbid them. 2)The PR is a legally required formal routine before the signature. In fact, probably they already engaging with the buyer.
0 · Reply
Chipoo
Chipoo Jun. 8 at 10:13 PM
$SGMO Wondering if today's PR is to shield SGMO from any lawsuits from warrent holders...
1 · Reply
Patrick2343
Patrick2343 Jun. 8 at 10:06 PM
$SGMO Notice all the pumpers have gone MIA too. The guy who usally pumps this every am. Soren. Even biotech toned it down.
0 · Reply
Scooter0732
Scooter0732 Jun. 8 at 9:51 PM
$SGMO this is the correct interpretation.
0 · Reply
kiwiSurfer
kiwiSurfer Jun. 8 at 9:17 PM
$SGMO the specious reasoning that a BK filing would allow shareholders to get residual value of assets is not correct generally they do not. The shareholders can and do get the shaft.
0 · Reply
kiwiSurfer
kiwiSurfer Jun. 8 at 9:15 PM
$SGMO bad Omen
0 · Reply
Wacousta
Wacousta Jun. 8 at 8:51 PM
$SGMO PR seems like a cover your buttocks document that is meant for BOD to be able to say they explored all alternatives before taking the low bid they got if any.
1 · Reply
Top_Dog_Pro_Trader
Top_Dog_Pro_Trader Jun. 8 at 8:20 PM
$SGMO no Gupta, we know they were in discussions before, and what BP wanted was more clarity on the rare disease approval process, which we have as of last week. BP also wanted more data on Fabry, which they now have as of yesterday. Let the negotiations begin!
1 · Reply
Patrick2343
Patrick2343 Jun. 8 at 8:05 PM
$SGMO At this point does anyone really believe this company will survive? Serious question.
1 · Reply
jlemx
jlemx Jun. 8 at 7:56 PM
$SGMO I think this is the correct interpretation of today PR. It sound like an administrative law formulation before closing an acquisition/ merge / sale or a similar process. Search using AI.
0 · Reply
Patrick2343
Patrick2343 Jun. 8 at 7:54 PM
$SGMO Soren has gone MIA. Tells you all you need to know about him.
0 · Reply
Guptasulo
Guptasulo Jun. 8 at 7:09 PM
$SGMO Many investors seem to think today's PR means SGMO has only just started exploring strategic alternatives. I don't believe that's the case. Back in April/May 2026, SGMO had already disclosed that: -it was being advised by a global investment bank, and -it was currently negotiating multiple potential business development transactions. Today's PR identified Raymond James and formally opens the strategic process by inviting any additional interested parties to engage. Independent investment bank not only because of the breadth of its assets, but also to ensure a transparent and competitive process for all stakeholders.( Prevents future allegations) This public process helps: -give any interested party an opportunity to participate, allow Raymond James to independently evaluate all proposals, -reduce future claims that one bidder or shareholder was unfairly treated or that better alternatives were not considered. Just like a final call submissions before it closes. My interpretations here.
3 · Reply
Herr_Chicken
Herr_Chicken Jun. 8 at 6:45 PM
$SGMO So Sangamo's relisting argument tomorrow is: We've got no deals, but we do have a banker now looking at strategic alternatives. And we've put out a press release showing all our impressive assets with an email address to contact for more info. Then there's this: "... [Sangamo] has retained Raymond James as its financial advisor to assist in evaluating a full range of strategic alternatives to advance its promising pipeline and to maximize value for all stakeholders." The use of "stakeholder" in this sentence is not a good omen for retail investors -- it's a much broader term that signals "we are considering our decisions and how they impact patients, employees, creditors, etc., and not just shareholders." If you have money on this now you are basically betting on a Raymond James-led "Hail Mary pass." Not impossible but a steep hill to climb at this point. The hearing tomorrow really forces them to show their hand and it's still a "no deal" hand, apparently.
6 · Reply
Dirtymartini66
Dirtymartini66 Jun. 8 at 6:24 PM
$SGMO might finally see $1 - $2 per share - best wishes all!
1 · Reply
popples69
popples69 Jun. 8 at 6:23 PM
$SGMO We don't know what's going on inside the company. No one's talking, and only a few press releases are being issued. After this outburst, I have to say: this is crazy!!! If they manage doctors the way they manage the company, I have serious doubts about the seriousness of the processes and treatments.... At this point, I'm truly speechless... amateurs at large!
1 · Reply
MakingMoneyHere
MakingMoneyHere Jun. 8 at 6:13 PM
$SGMO This company is total JOKE 🤣
0 · Reply
Patrick2343
Patrick2343 Jun. 8 at 5:51 PM
$SGMO The real question is how do then intend to survive with one month of cash these deals take months minumum.
1 · Reply